← FDA Drug Approvals (Drugs@FDA)

SUFENTANIL CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 1996-12-11

Drug application

FDA Application #

ANDA074534

Application type

Abbreviated New Drug Application (Generic)

Brand name

SUFENTANIL CITRATE

Generic name

SUFENTANIL CITRATE

Active ingredients

SUFENTANIL CITRATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HOSPIRA

Manufacturer

Hospira, Inc.

First approval

1996-12-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown